In addition, research has shown that SMAD4 point mutations occur in a very small number of cases of kidney cancer, esophageal cancer, and cholangiocarcinoma.25–27 Although such point mutations are rare, other drivers, such as alternative splicing and protein loss, are common in cancer, thus providing some explanation for these types of mutations. This evidence concerns the gene SMAD4 and cancer.